Publications found:
156
Sort by:
Tuberculosis Therapeutics Market - Global Industry Size, Share, Trends, Opportunity & Forecast, Segmented By Disease Type (Active TB, Latent TB), By Therapy (First-Line Therapy, Second-Line Therapy), By Route of Administration (Oral, Parenteral, Others), By Dosage Form (Tablets, Capsules, Injection, Others), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Tuberculosis Therapeutics Market is projected to grow from USD 2.27 Billion in 2025 to USD 3.14 Billion by 2031, achieving a Compound Annual Growth Rate of 5.56%. This market focuses on the...
May 2026
185 pages
Anti-Tuberculosis Therapeutics Market – Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Disease Type (Active TB, Latent TB, Others), By Diagnosis and Treatment (Diagnosis (Blood Tests, Imaging Tests, Sputum Tests, Others), Treatment (First Line of Drugs, Second Line of Drugs, others), others), By End User (Hospitals, Specialty Clinics, Homecare, others), By Region & Competition, 2021-2031F
US$ 4,500.00
The global anti-tuberculosis therapeutics market is projected to expand significantly, from USD 1411.21 million in 2025 to USD 1995.04 million by 2031, achieving a compound annual growth rate of 5.94%...
May 2026
180 pages
Biofilms Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product ( Debridement Equipment, Gauzes & Dressings, Gels, Ointments & Sprays Grafts & Matrices, Wipes, Pads & Lavage Solutions), By Wound Type (Burns & Open Wounds, Diabetic Foot Ulcers, Pressure Ulcers, Traumatic & Surgical Wounds, Venous Leg Ulcers), By End user (Home Care Settings, Hospitals, ASCs & Wound Care Centers), By Region & Competition, 2021-2031F
US$ 4,500.00
The global market for biofilm treatment is projected to expand from USD 1.82 billion in 2025 to USD 2.52 billion by 2031, demonstrating a 5.57% compound annual growth rate. This market includes specia...
May 2026
192 pages
Herpes Zoster Infection Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Treatment Type (Prescription Treatment, Supporting Treatment), By Route of administration (Oral, Intravenous, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Herpes Zoster Infection Treatment Market is projected to expand from USD 271.12 Million in 2025 to USD 341.47 Million by 2031, achieving a Compound Annual Growth Rate of 3.92%. This market...
May 2026
185 pages
Human Papillomavirus (HPV) Associated Disorders Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Indication (AIN, Anal Cancer, Cervical Cancer, CIN, Genital Warts), By Therapy ( Prevention, Treatment), By End user (Hospitals & Clinics, Ambulatory Care Centers, Others), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Human Papillomavirus (HPV) Associated Disorders Market is projected to grow from USD 28.23 billion in 2025 to USD 40.57 billion by 2031, at a compound annual growth rate (CAGR) of 6.23%. Th...
May 2026
180 pages
Bird Flu Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type (Antivirals, Combination Treatment, Prophylactic Antibiotics, Ribavirin), By End-User (Clinics, Hospitals, Institutional Health Centers, Others), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Bird Flu Treatment Market is projected to expand from a valuation of USD 26.15 Billion in 2025 to USD 43.09 Billion by 2031, reflecting a compound annual growth rate of 8.68%. This market e...
May 2026
180 pages
Pseudomonas Aeruginosa Infection Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Medication Type (Monotherapy, Combination Therapy), By Drug Type (Aminoglycoside, Cephalosporin, Carbapenem, Monobactam, Others), By Route Of Administration (Nasal, Oral, Intravenous), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Pseudomonas Aeruginosa Infection Treatment Market is projected to expand from USD 2.31 Billion in 2025 to USD 3.34 Billion by 2031, reflecting a compound annual growth rate of 6.34%. This m...
May 2026
188 pages
Q Fever Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type (Acute Q Fever, Chronic Q Fever), By Medication Type (Antibiotics, Antimalerial, Corticosteroids, Others), By End-Users (Hospitals, Clinics, Research Institutes), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Q Fever Market is projected to increase from USD 441.31 Million in 2025 to USD 598.53 Million by 2031, expanding at a CAGR of 5.21%. This market covers the creation and distribution of diag...
May 2026
180 pages
Bacterial Pneumonia Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type (Community-Acquired Pneumonia (CAP), Hospital-Acquired Pneumonia (HAP)), By Treatments (Vaccines, Drugs), By Route of Administration (Oral, Subcutaneous, Other), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Bacterial Pneumonia Market is projected to expand significantly, rising from USD 2.64 Billion in 2025 to USD 4.02 Billion by 2031, demonstrating a compound annual growth rate (CAGR) of 7.26...
May 2026
180 pages
Viral Gastroenteritis Market Forecasts to 2034 – Global Analysis By Type (Norovirus, Rotavirus, Astrovirus, Enteric Adenovirus and Other Types), Diagnosis (Physical Examination and Rapid Stool Test), Treatment (Intravenous Fluids, Antimotility Agents, Electrolytes, Antiemetic Drugs, Antidiarrheal Drugs and Other Treatments), Drug (Antibiotics, Antacids, Laxatives, Antimotility Agents, Antiemetics, Chemotherapy Drugs and Other Drugs), Dosage, Indication, Route of Administration, Distribution Channel, End User and by Geography
US$ 4,150.00
According to Stratistics MRC, the Global Viral Gastroenteritis Market is accounted for $57.0 billion in 2026 and is expected to reach $95.1 billion by 2034 growing at a CAGR of 6.6% during the forecas...
April 2026
200 pages
Hospital Acquired Infections Market - 2025
US$ 2,999.00
The Hospital Acquired Infections Market was valued at USD 16.10 billion in 2025 and is anticipated to reach by , at a CAGR of 0.038 from 2026 to 2032. The report delivers in-depth insights into key ma...
April 2026
207 pages
Tuberculosis Drug Market - 2025-2033
US$ 2,999.00
The Tuberculosis Drug Market was valued at US$ 2.57 Billion in 2025 and is anticipated to reach US$ 3.78 Billion by 2033, at a CAGR of 0.049 from 2026 to 2032. The report delivers in-depth insights in...
February 2026
220 pages
Global Clostridium Difficile Market Growth 2026-2032
US$ 3,660.00
The global Clostridium Difficile market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032. Clostridium Difficile is a ba...
February 2026
82 pages
Sepsis Treatment Market 2026
US$ 2,999.00
The Sepsis Treatment Market was valued at in and is anticipated to reach by , at a CAGR of 0.095 from 2026 to 2032. The report delivers in-depth insights into key market dynamics, including regional g...
February 2026
220 pages
Typhoid Fever Market - 2024-2033
US$ 2,999.00
The Typhoid Fever Market was valued at US$ 373.72Million in 2024 and is anticipated to reach US$ 858.77Million by 2033, at a CAGR of 0.097 from 2026 to 2032. The report delivers in-depth insights into...
January 2026
223 pages
Global Lamivudine Drugs Market Growth 2026-2032
US$ 3,660.00
The global Lamivudine Drugs market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032. Lamivudine is an oral antiviral me...
January 2026
132 pages
Global Oral Adefovir Drugs Market Growth 2026-2032
US$ 3,660.00
The global Oral Adefovir Drugs market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032. Oral adefovir drugs are an anti...
January 2026
113 pages
Herpes Labialis Drugs Market - 2023-2031
US$ 2,999.00
The Herpes Labialis Drugs Market was valued at US$ 1.16 billion in 2023 and is anticipated to reach US$ 1.7 billion by 2031, at a CAGR of 0.048 from 2026 to 2032. The report delivers in-depth insights...
January 2026
200 pages
Invasive Fungal Infection Treatment Market - 2023-2031
US$ 2,999.00
The Invasive Fungal Infection Treatment Market was valued at US$ 10.6 billion in 2023 and is anticipated to reach US$ 14.6 billion by 2031, at a CAGR of 0.041 from 2026 to 2032. The report delivers in...
January 2026
219 pages
Chlamydia Infection Treatment Market - 2023-2031
US$ 2,999.00
The Chlamydia Infection Treatment Market was valued at US$ 1.71 billion in 2023 and is anticipated to reach US$ 2.46 billion by 2031, at a CAGR of 0.047 from 2026 to 2032. The report delivers in-depth...
January 2026
218 pages
Global Acinetobacter Infections Treatment Market 2026 by Company, Regions, Type and Application, Forecast to 2032
US$ 3,480.00
... manufacturers of Acinetobacter Infections Treatment, with price, sales, revenue and global market share of Acinetobacter Infections Treatment in 2017 and 2018. Chapter 3, the Acinetobacter Infections Treatment competitive situation, sales, revenue and global market share ...
January 2026
114 pages
Global Hospital-Acquired Pneumonia Prevention Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032
US$ 3,480.00
... the global Hospital-Acquired Pneumonia Prevention market. Chapter 1, to describe Hospital-Acquired Pneumonia Prevention Introduction, product scope, market overview, market opportunities, market risk, market driving force; Chapter 2, to analyze the top manufacturers of Hospital-Acquired Pneumonia Prevention ...
January 2026
95 pages
The 2027-2032 World Outlook for Anti-Jamming
US$ 1,195.00
This study covers the world outlook for anti-jamming across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the...
January 2026
287 pages
The 2027-2032 World Outlook for Communicable Diseases
US$ 1,195.00
This study covers the world outlook for communicable diseases across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.)...
January 2026
288 pages
The 2027-2032 World Outlook for Community Acquired Pneumonia
US$ 1,195.00
This study covers the world outlook for community acquired pneumonia across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (...
January 2026
290 pages
The 2027-2032 World Outlook for Cryptococcosis
US$ 1,195.00
This study covers the world outlook for cryptococcosis across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for t...
January 2026
287 pages
